PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.24%
Revenue growth of 19.24% while 1177.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
34.44%
Gross profit growth of 34.44% while 1177.HK is zero. Bruce Berkowitz would see if minimal improvements could expand further.
205.59%
EBIT growth of 205.59% while 1177.HK is zero. Bruce Berkowitz would see if small gains can be scaled further.
191.41%
Operating income growth of 191.41% while 1177.HK is zero. Bruce Berkowitz would see if this modest edge can become significant.
257.75%
Net income growth of 257.75% while 1177.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
258.37%
EPS growth of 258.37% while 1177.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
247.06%
Diluted EPS growth of 247.06% while 1177.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.35%
Share change of 0.35% while 1177.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.58%
Diluted share change of 3.58% while 1177.HK is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Dividend reduction while 1177.HK stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
3.36%
OCF growth of 3.36% while 1177.HK is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
-100.49%
Negative FCF growth while 1177.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
728.74%
5Y revenue/share CAGR above 1.5x 1177.HK's 82.99%. David Dodd would look for consistent product or market expansions fueling outperformance.
172.01%
3Y revenue/share CAGR above 1.5x 1177.HK's 8.79%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
381.65%
5Y OCF/share CAGR above 1.5x 1177.HK's 84.48%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
361.39%
3Y OCF/share CAGR above 1.5x 1177.HK's 34.23%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
No Data
No Data available this quarter, please select a different quarter.
216.83%
5Y net income/share CAGR above 1.5x 1177.HK's 60.56%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
172.83%
3Y net income/share CAGR above 1.5x 1177.HK's 47.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
0.56%
Below 50% of 1177.HK's 204.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
23.35%
Positive short-term equity growth while 1177.HK is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.54%
Inventory growth of 2.54% while 1177.HK is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
3.96%
Asset growth of 3.96% while 1177.HK is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
6.34%
BV/share growth of 6.34% while 1177.HK is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
0.30%
Debt growth far above 1177.HK's 0.41%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
1.35%
SG&A growth of 1.35% while 1177.HK is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.